Affirma Biotech is a pre-clinical startup which develops host-directed drugs as treatments for chronic and infection diseases.
Affirma Biotech has raised $1.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.
Affirma Biotech's investors include SeedBlink, Centre for the Development of Industrial Technology (CDTI), Capital Cell, Reig Jofre, GENESIS Biomed.
Affirma Biotech is headquartered in Barcelona, Spain.
Affirma Biotech is a pre-clinical startup which develops host-directed drugs as treatments for chronic and infection diseases.
Affirma Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Affirma Biotech — Funding & Investors." VCBacked, February 1, 2024, https://www.vcbacked.co/company/affirma-biotech. Accessed August 13, 2026.
VCBacked. (2024). Affirma Biotech — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/affirma-biotech
{{cite web |title=Affirma Biotech — Funding & Investors |url=https://www.vcbacked.co/company/affirma-biotech |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated